# FDA 483 - Invitrx Therapeutics Inc. - April 30, 2025

Source: https://www.globalkeysolutions.net/records/483/invitrx-therapeutics-inc/8e20c736-81a1-4164-ad17-4d5883461c2d

> FDA 483 for Invitrx Therapeutics Inc. on April 30, 2025. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Invitrx Therapeutics Inc.
- Inspection Date: 2025-04-30
- Product Type: biologics
- Office Name: Los Angeles District Office

## Related Documents

- [WARNING_LETTER - 2019-04-03](https://www.globalkeysolutions.net/records/warning_letter/invitrx-therapeutics-inc/609c196c-c4a1-4fb7-80a4-7aff1231849d)
- [483 - 2022-03-22](https://www.globalkeysolutions.net/records/483/invitrx-therapeutics-inc/f2c132a4-92b9-498a-ad13-42a0d14479e9)

## Related Officers

- [Laurissa S. Flowers](https://www.globalkeysolutions.net/people/laurissa-s-flowers/27453525-c2fc-4a05-9cdc-7a1ed884304f)
- [Creighton T. Tuzon](https://www.globalkeysolutions.net/people/creighton-t-tuzon/be0d09c0-59f4-48c3-9e3d-a1ceb2587e3e)

Company: https://www.globalkeysolutions.net/companies/invitrx-therapeutics-inc/56153bdd-2935-4184-99ff-28af39f1fc61

Office: https://www.globalkeysolutions.net/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b